TFC Financial Management’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
TFC Financial Management's PVLA Position: Q3 2026 in Review
TFC Financial Management held its Palvella Therapeutics (PVLA) position steady in Q3 2026 at 1 share worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #879.
TFC Financial Management first reported a position in PVLA in Q1 2026 and has held it in 3 quarters since. The position peaked at $153 in Q2 2026. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- TFC Financial Management held 1 share of Palvella Therapeutics worth $138 as of Q3 2026.
- TFC Financial Management left its Palvella Therapeutics share count unchanged in Q3 2026.
- Palvella Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #879 holding.
- TFC Financial Management first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 3 quarters since.
- TFC Financial Management's Palvella Therapeutics position peaked at $153 in Q2 2026.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.